- Home
- FCUV vs PASG Comparison
FCUV vs PASG Comparison
Compare FCUV & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- PASG
- Stock Information
- Founded
- FCUV 2012
- PASG 2017
- Country
- FCUV United States
- PASG United States
- Employees
- FCUV 46
- PASG N/A
- Industry
- FCUV Industrial Machinery/Components
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- FCUV Industrials
- PASG Health Care
- Exchange
- FCUV Nasdaq
- PASG Nasdaq
- Market Cap
- FCUV 31.5M
- PASG 27.6M
- IPO Year
- FCUV N/A
- PASG 2020
- Fundamental
- Price
- FCUV $4.29
- PASG $7.70
- Analyst Decision
- FCUV
- PASG Strong Buy
- Analyst Count
- FCUV 0
- PASG 4
- Target Price
- FCUV N/A
- PASG $59.25
- AVG Volume (30 Days)
- FCUV 56.6K
- PASG 37.6K
- Earning Date
- FCUV 11-14-2025
- PASG 11-10-2025
- Dividend Yield
- FCUV N/A
- PASG N/A
- EPS Growth
- FCUV N/A
- PASG N/A
- EPS
- FCUV N/A
- PASG N/A
- Revenue
- FCUV $432,983.00
- PASG N/A
- Revenue This Year
- FCUV N/A
- PASG N/A
- Revenue Next Year
- FCUV N/A
- PASG N/A
- P/E Ratio
- FCUV N/A
- PASG N/A
- Revenue Growth
- FCUV 140.82
- PASG N/A
- 52 Week Low
- FCUV $1.80
- PASG $5.12
- 52 Week High
- FCUV $10.90
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- FCUV 57.42
- PASG 48.68
- Support Level
- FCUV $3.87
- PASG $6.82
- Resistance Level
- FCUV $4.37
- PASG $7.90
- Average True Range (ATR)
- FCUV 0.46
- PASG 0.61
- MACD
- FCUV -0.01
- PASG -0.13
- Stochastic Oscillator
- FCUV 54.50
- PASG 40.32
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.